Immune recognition and immunotherapy in hematological malignancies

被引：0
|
作者：
Orsini, E
Guarini, A
Torelli, G
Foá, R
机构：
[1] Univ Roma La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, Rome, Italy
[2] Univ Turin, Dipartimento Sci Biomed & Oncol Umana, Turin, Italy
来源：
MINERVA BIOTECNOLOGICA | 1999年 / 11卷 / 04期
关键词：
immunotherapy; immunorecognition; immunoplasty; hematological neoplasms;
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
In the present review, we shall discuss how immunotherapy has, over the last 15 years, become a prominent part of the therapeutic armamentarium for different types of hematological malignancies. We will also focus on new prospects in rapid and promising development, as well as on possibilities of inducing immune-mediated recognition of leukemia and lymphoma cells.
引用
收藏
页码：325 / 334
页数：10
相关论文
共 50 条
  • [41] Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy Drugs
    Innao, Vanessa
    Rizzo, Vincenzo
    Allegra, Andrea Gaetano
    Musolino, Caterina
    Allegra, Alessandro
    CURRENT ONCOLOGY, 2021, 28 (01) : 159 - 183
  • [42] Nanomedicine for Immunotherapy Targeting Hematological Malignancies: Current Approaches and Perspective
    Allegra, Alessandro
    Di Gioacchino, Mario
    Tonacci, Alessandro
    Petrarca, Claudia
    Gangemi, Sebastiano
    NANOMATERIALS, 2021, 11 (11)
  • [43] Does chemotherapy modify the immune surveillance of hematological malignancies?
    A J Barrett
    B N Savani
    Leukemia, 2009, 23 : 53 - 58
  • [44] Does chemotherapy modify the immune surveillance of hematological malignancies?
    Barrett, A. J.
    Savani, B. N.
    LEUKEMIA, 2009, 23 (01) : 53 - 58
  • [45] Toxicity of Immune-Checkpoint Inhibitors in Hematological Malignancies
    Hradska, Katarina
    Hajek, Roman
    Jelinek, Tomas
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [46] Innate Immune Mechanisms and Immunotherapy of Myeloid Malignancies
    Small, Sara
    Numan, Yazan
    Platanias, Leonidas C.
    BIOMEDICINES, 2021, 9 (11)
  • [47] Donor lymphocyte infusion - An adaptive cellular immunotherapy for treatment of hematological malignancies
    Owaidah, TM
    SAUDI MEDICAL JOURNAL, 2003, 24 (02) : 138 - 141
  • [48] Guest editorial: immunotherapy for hematological malignancies: the quest to overcome tolerogenic drive
    Norimitsu Kadowaki
    International Journal of Hematology, 2014, 99 : 105 - 106
  • [49] Emerging Therapeutic Targets and Drug Resistance Mechanisms in Immunotherapy of Hematological Malignancies
    Olejarz, Wioletta
    Basak, Grzegorz
    CANCERS, 2023, 15 (24)
  • [50] T Cell Exhaustion and CAR-T Immunotherapy in Hematological Malignancies
    Tang, Lu
    Zhang, Yinqiang
    Hu, Yu
    Mei, Heng
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
12345